Spoknwrdclinicaltrials

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Sickle cell disease

Closed trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  NCT06439082· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals